Literature DB >> 12497558

Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration.

Y A L Pijnenburg1, E L Sampson, R J Harvey, N C Fox, M N Rossor.   

Abstract

BACKGROUND: Frontotemporal lobar degeneration (FTLD) is commonly associated with behavioural disturbances such as disinhibition and aggression; these often result in the use of neuroleptic medication.
METHODS: All available case notes of patients attending a specialist cognitive disorders clinic with a diagnosis of FTLD were selected. This gave 100 subjects (62 male, 38 female).
RESULTS: In 61 patients significant behavioural disturbances were present. Of these patients, 24 had been prescribed neuroleptics. Significant extrapyramidal side effects were reported in eight patients (33%); in five patients these were severe enough to cause severe mobility problems and in one patient resulted in impaired consciousness. In some instances the extrapyramidal side effects took weeks to wear off.
CONCLUSION: These results suggest that patients with FTLD may, as in Lewy body dementia, be particularly sensitive to the extrapyramidal side effects of neuroleptics. We suggest that neuroleptics should be used cautiously in FTLD and treatment should be started at low doses avoiding depot preparations until further prospective studies have been performed. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12497558     DOI: 10.1002/gps.774

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  22 in total

Review 1.  [Frontotemporal dementia: specific problems for caregivers].

Authors:  Janine Diehl; H Förstl; S Jansen; A Kurz
Journal:  Z Gerontol Geriatr       Date:  2004-08       Impact factor: 1.281

Review 2.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 3.  Young-onset dementia.

Authors:  Dulanji K Kuruppu; Brandy R Matthews
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 4.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Psychotic symptoms in frontotemporal dementia.

Authors:  Devin Hall; Elizabeth C Finger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 6.  Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Authors:  Geoffrey A Kerchner; Maria Carmela Tartaglia; Adam Boxer
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

7.  Treatment of frontotemporal dementia.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 8.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 9.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 10.  Diagnosis and management of behavioral variant frontotemporal dementia.

Authors:  Peter S Pressman; Bruce L Miller
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.